Polar Asset Management Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,700
| Closed | -$455K | – | 813 |
|
|
2023
Q4 | $455K | Sell |
3,700
-27,800
| -88% | -$3.42M | 0.01% | 441 |
|
|
2023
Q3 | $4.08M | Sell |
31,500
-5,000
| -14% | -$647K | 0.09% | 252 |
|
|
2023
Q2 | $4.52M | Sell |
36,500
-185,100
| -84% | -$22.9M | 0.08% | 296 |
|
|
2023
Q1 | $32.4M | Buy |
221,600
+69,900
| +46% | +$10.2M | 0.49% | 17 |
|
|
2022
Q4 | $24.2M | Sell |
151,700
-13,900
| -8% | -$2.21M | 0.3% | 47 |
|
|
2022
Q3 | $22.1M | Buy |
165,600
+3,500
| +2% | +$467K | 0.26% | 57 |
|
|
2022
Q2 | $25.3M | Buy |
162,100
+2,600
| +2% | +$406K | 0.29% | 52 |
|
|
2022
Q1 | $24.8M | Buy |
159,500
+55,900
| +54% | +$8.7M | 0.27% | 56 |
|
|
2021
Q4 | $13.2M | Buy |
103,600
+65,900
| +175% | +$8.4M | 0.14% | 159 |
|
|
2021
Q3 | $4.91M | Buy |
+37,700
| New | +$4.91M | 0.05% | 354 |
|